美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

FibroBiologics

0.7120

-0.0235-3.20%

盤後：0.7015-0.0105-1.47%19:45 EDT

成交量：5.24萬

成交額：3.79萬

市值：432.94萬

市盈率：-0.10

高：0.7540

開：0.7540

低：0.7000

收：0.7355

52周最高：14.40

52周最低：0.7000

股本：608.06萬

流通股本：542.34萬

量比：0.57

換手率：0.97%

股息：- -

股息率：- -

每股收益(TTM):-6.8785

每股收益(LYR):-8.3501

淨資產收益率：-754.75%

總資產收益率：-123.72%

市淨率：1.67

市盈率(LYR):-0.09

資料載入中...

總覽公司新聞公告

FibroBiologics提交SEC文件：註冊出售股東至多1253萬股普通股轉售

FibroBiologics完成第三批Cywc628藥物生產，用於糖尿病足潰瘍1/2期臨床試驗

FibroBiologics宣佈完成最高900萬美元按市價定價的私募配售

FibroBiologics獲美國專利授權通知，覆蓋用於傷口癒合的局部成纖維細胞球體療法

FibroBiologics推進針對糖尿病足潰瘍的Ciwc628藥物1/2期臨床試驗患者給藥

FibroBiologics宣佈首批患者接受Cywc628治療糖尿病足潰瘍的1/2期臨床試驗給藥

新聞稿：FibroBiologics 在皮膚研究學會2026年會上公布臨床前數據，展示其銀屑病療法持久的免疫調節作用

FibroBiologics啓動1/2期臨床試驗評估CYWc628對糖尿病足潰瘍患者的安全性、耐受性及療效

FibroBiologics宣佈Cywc628藥物產品完成生產將用於糖尿病足潰瘍1/2期臨床試驗

FibroBiologics達成ATM發行協議擬發售最高615萬美元普通股

FibroBiologics與United Fire & Casualty簽訂租約終止協議，生效日期為2026年4月3日

FibroBiologics宣佈成功生產Cywc628藥物產品，為即將開展的糖尿病足潰瘍臨床試驗提供支持

FibroBiologics宣佈實施合股計劃，旨在重新符合納斯達克最低買入價規定

Fibrobiologics, Inc.盤中異動早盤急速下跌5.30%報0.375美元

Fibrobiologics, Inc.盤中異動大幅上漲5.94%

FibroBiologics完成針對難治性糖尿病足潰瘍的Cywc628一期/二期臨床試驗中心啓動工作

FibroBiologics公司宣佈獲得美國專利，涵蓋用於治療骨質疏鬆的成纖維細胞療法

Fibrobiologics, Inc.盤中異動早盤快速拉升5.34%

Fibrobiologics, Inc.盤中異動早盤股價大跌5.58%報0.241美元

FibroBiologics獲加拿大專利授權，覆蓋基於成纖維細胞的惡病質創新療法

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/FBLG/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FBLG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBLG\",,,,,undefined,":{"symbol":"FBLG","market":"US","secType":"STK","nameCN":"FibroBiologics","latestPrice":0.712,"timestamp":1784923200000,"preClose":0.7355,"halted":0,"volume":52376,"hourTrading":{"tag":"盘后","latestPrice":0.7015,"preClose":0.712,"latestTime":"19:45 EDT","volume":16320,"amount":11663.8576,"timestamp":1784936743457,"change":-0.0105,"changeRate":-0.014747,"amplitude":0.091292},"delay":0,"changeRate":-0.03195105370496271,"floatShares":5423400,"shares":6080599,"eps":-6.878533,"marketStatus":"休市中","change":-0.0235,"latestTime":"07-24 16:00:00 EDT","open":0.754,"high":0.754,"low":0.7,"amount":37862.5213608,"amplitude":0.073419,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.878533,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1785139200000},"marketStatusCode":7,"adr":0,"listingDate":1706677200000,"exchange":"NASDAQ","adjPreClose":0.7355,"preHourTrading":{"tag":"盘前","latestPrice":0.7301,"preClose":0.7355,"latestTime":"09:16 EDT","volume":2140,"amount":1649.979804,"timestamp":1784898972388,"change":-0.0054,"changeRate":-0.007342,"amplitude":0.163154},"postHourTrading":{"tag":"盘后","latestPrice":0.7015,"preClose":0.712,"latestTime":"19:45 EDT","volume":16320,"amount":11663.8576,"timestamp":1784936743457,"change":-0.0105,"changeRate":-0.014747,"amplitude":0.091292},"volumeRatio":0.5747267696447314},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FBLG\",,,,,undefined,":{"symbol":"FBLG","floatShares":5423400,"roa":"-123.72%","roe":"-754.75%","lyrEps":-8.3501,"volumeRatio":0.5747267696447314,"shares":6080599,"dividePrice":0,"high":0.754,"amplitude":0.073419,"preClose":0.7355,"low":0.7,"week52Low":0.7,"pbRate":"1.67","week52High":14.396,"institutionHeld":0,"latestPrice":0.712,"eps":-6.878533,"divideRate":0,"volume":52376,"delay":0,"ttmEps":-6.878533,"open":0.754,"prevYearClose":4.498,"prevWeekClose":0.8349,"prevMonthClose":0.9477,"prevQuarterClose":0.9477,"fiveDayClose":0.8349,"twentyDayClose":0.7332,"sixtyDayClose":1.36},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FBLG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-04-30","symbol":"FBLG","fiscalQuarterEnding":"2026/03","expectedEps":-1.26,"name":null,"time":"盤後","type":"earning","dateTimestamp":1777521600000,"reportTimeType":"post","actualEps":-1.33},{"market":"US","date":"2026-03-30","symbol":"FBLG","defaultRemindTime":1774877400000,"type":"split","dateTimestamp":1774843200000,"forFactor":20,"toFactor":1,"ratio":20},{"market":"US","date":"2026-02-24","symbol":"FBLG","fiscalQuarterEnding":"2025/12","expectedEps":-0.09,"name":null,"time":"盤後","type":"earning","dateTimestamp":1771909200000,"reportTimeType":"post","actualEps":-0.03},{"market":"US","date":"2025-10-31","symbol":"FBLG","fiscalQuarterEnding":"2025/09","expectedEps":-0.1,"name":null,"time":"盤後","type":"earning","dateTimestamp":1761883200000,"reportTimeType":"post","actualEps":-0.13},{"market":"US","date":"2025-07-31","symbol":"FBLG","fiscalQuarterEnding":"2025/06","expectedEps":-0.11,"name":null,"time":"盤後","type":"earning","dateTimestamp":1753934400000,"reportTimeType":"post","actualEps":-0.12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FBLG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FBLG\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1777953600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FBLG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FBLG","date":"2026-07-24","current":-0.10351,"percent":0.998336,"low":-68.573467,"twenty":-5.964951,"median":-3.025992,"eighty":-0.912766,"high":-0.211918,"avg":-6.064407,"sd":9.689903,"marketCap":3971046},"quantilePoints":[{"date":"2024-02-02","current":-68.573467,"twenty":-68.573467,"median":-68.573467,"eighty":-68.573467,"marketCap":568611190},{"date":"2024-02-09","current":-30.642544,"twenty":-58.777258,"median":-48.452053,"eighty":-34.01244,"marketCap":254087971},{"date":"2024-02-16","current":-50.313332,"twenty":-58.777258,"median":-50.313332,"eighty":-30.642544,"marketCap":417198153},{"date":"2024-02-23","current":-47.413654,"twenty":-56.896385,"median":-48.5892,"eighty":-33.338461,"marketCap":393154022},{"date":"2024-03-01","current":-25.741365,"twenty":-54.984165,"median":-48.491237,"eighty":-33.338461,"marketCap":424346408},{"date":"2024-03-08","current":-19.47356,"twenty":-53.244359,"median":-47.492024,"eighty":-25.717713,"marketCap":321021631},{"date":"2024-03-15","current":-20.892685,"twenty":-51.363486,"median":-37.245189,"eighty":-20.955758,"marketCap":344415920},{"date":"2024-03-22","current":-23.849198,"twenty":-50.446561,"median":-28.99678,"eighty":-20.813845,"marketCap":393154022},{"date":"2024-03-28","current":-23.159345,"twenty":-50.219289,"median":-25.741365,"eighty":-20.93999,"marketCap":381781799},{"date":"2024-04-05","current":-22.469492,"twenty":-49.216157,"median":-24.637601,"eighty":-21.160743,"marketCap":370409575},{"date":"2024-04-12","current":-22.311811,"twenty":-48.471645,"median":-23.652097,"eighty":-21.298713,"marketCap":367810209},{"date":"2024-04-19","current":-21.700799,"twenty":-48.064123,"median":-23.20862,"eighty":-21.030656,"marketCap":357737668},{"date":"2024-04-26","current":-23.021374,"twenty":-47.63309,"median":-22.804563,"eighty":-21.030656,"marketCap":379507354},{"date":"2024-05-03","current":-13.245174,"twenty":-47.445002,"median":-22.479347,"eighty":-20.675875,"marketCap":218346696},{"date":"2024-05-10","current":-17.22661,"twenty":-43.252224,"median":-22.05558,"eighty":-19.871704,"marketCap":283980674},{"date":"2024-05-17","current":-17.017594,"twenty":-36.598639,"median":-21.769784,"eighty":-19.221271,"marketCap":383406402},{"date":"2024-05-24","current":-16.310932,"twenty":-31.990502,"median":-21.661379,"eighty":-18.255477,"marketCap":367485289},{"date":"2024-05-31","current":-17.767522,"twenty":-29.984238,"median":-21.543118,"eighty":-17.827098,"marketCap":400302277},{"date":"2024-06-07","current":-14.972667,"twenty":-28.19741,"median":-21.306597,"eighty":-17.252609,"marketCap":337334178},{"date":"2024-06-14","current":-10.427133,"twenty":-26.746956,"median":-21.178482,"eighty":-16.659936,"marketCap":234923317},{"date":"2024-06-21","current":-7.769521,"twenty":-25.741365,"median":-20.932105,"eighty":-16.368618,"marketCap":175047318},{"date":"2024-06-28","current":-6.767471,"twenty":-25.694061,"median":-20.88283,"eighty":-16.302279,"marketCap":152471122},{"date":"2024-07-05","current":-6.143005,"twenty":-25.43783,"median":-20.64631,"eighty":-15.81876,"marketCap":138401898},{"date":"2024-07-12","current":-7.689204,"twenty":-24.673079,"median":-20.183123,"eighty":-14.136173,"marketCap":173237756},{"date":"2024-07-15","current":-7.514809,"twenty":-24.649427,"median":-20.094427,"eighty":-13.517924,"marketCap":169308652},{"date":"2024-08-02","current":-7.974576,"twenty":-24.625775,"median":-20.005732,"eighty":-13.175194,"marketCap":179667198},{"date":"2024-08-09","current":-4.080921,"twenty":-24.140907,"median":-19.700225,"eighty":-10.836667,"marketCap":79459622},{"date":"2024-08-16","current":-2.166861,"twenty":-23.730937,"median":-18.842837,"eighty":-9.439605,"marketCap":42190950},{"date":"2024-08-23","current":-2.546062,"twenty":-23.640271,"median":-18.638558,"eighty":-7.79743,"marketCap":49574366},{"date":"2024-08-30","current":-2.915474,"twenty":-23.407692,"median":-18.172694,"eighty":-7.552859,"marketCap":56767191},{"date":"2024-09-06","current":-3.368187,"twenty":-23.218475,"median":-17.767522,"eighty":-6.924314,"marketCap":65581972},{"date":"2024-09-13","current":-5.722296,"twenty":-23.104157,"median":-17.428613,"eighty":-6.143005,"marketCap":111418835},{"date":"2024-09-20","current":-5.722296,"twenty":-22.93465,"median":-17.22661,"eighty":-5.90745,"marketCap":111418835},{"date":"2024-09-27","current":-5.686079,"twenty":-22.765143,"median":-16.563311,"eighty":-5.873037,"marketCap":110713652},{"date":"2024-10-04","current":-4.798761,"twenty":-22.619289,"median":-16.368618,"eighty":-5.722296,"marketCap":93436681},{"date":"2024-10-11","current":-4.20118,"twenty":-22.481318,"median":-16.080185,"eighty":-5.265962,"marketCap":81801170},{"date":"2024-10-18","current":-6.012033,"twenty":-22.40642,"median":-15.807485,"eighty":-5.066768,"marketCap":117060295},{"date":"2024-10-25","current":-5.215258,"twenty":-22.209319,"median":-15.237992,"eighty":-5.131958,"marketCap":101546280},{"date":"2024-10-31","current":-5.342017,"twenty":-22.020102,"median":-13.586112,"eighty":-5.110228,"marketCap":104014418},{"date":"2024-11-08","current":-6.464746,"twenty":-21.866364,"median":-12.649071,"eighty":-5.128337,"marketCap":125875076},{"date":"2024-11-15","current":-5.477931,"twenty":-21.799349,"median":-10.768411,"eighty":-5.146445,"marketCap":97392141},{"date":"2024-11-22","current":-4.698155,"twenty":-21.716567,"median":-9.773622,"eighty":-5.018763,"marketCap":83528491},{"date":"2024-11-29","current":-5.107537,"twenty":-21.700799,"median":-9.003931,"eighty":-5.016064,"marketCap":90806907},{"date":"2024-12-06","current":-4.639671,"twenty":-21.661379,"median":-7.895306,"eighty":-4.997955,"marketCap":82488717},{"date":"2024-12-13","current":-4.425233,"twenty":-21.562828,"median":-7.720912,"eighty":-4.979847,"marketCap":78676213},{"date":"2024-12-20","current":-3.957367,"twenty":-21.543118,"median":-7.546517,"eighty":-4.853087,"marketCap":70358023},{"date":"2024-12-27","current":-4.50321,"twenty":-21.511582,"median":-7.203145,"eighty":-4.778145,"marketCap":80062578},{"date":"2025-01-03","current":-3.869642,"twenty":-21.385437,"median":-6.905845,"eighty":-4.698155,"marketCap":68798363},{"date":"2025-01-10","current":-4.065278,"twenty":-21.306597,"median":-6.609614,"eighty":-4.652603,"marketCap":72276579},{"date":"2025-01-17","current":-3.769263,"twenty":-21.298713,"median":-6.286711,"eighty":-4.50321,"marketCap":67013721},{"date":"2025-01-24","current":-3.157497,"twenty":-21.243525,"median":-6.193118,"eighty":-4.433031,"marketCap":56137148},{"date":"2025-01-31","current":-3.295638,"twenty":-21.050366,"median":-6.140899,"eighty":-4.36675,"marketCap":58593149},{"date":"2025-02-07","current":-3.157497,"twenty":-20.955758,"median":-6.004281,"eighty":-4.203103,"marketCap":56137148},{"date":"2025-02-14","current":-2.545732,"twenty":-20.888743,"median":-5.948653,"eighty":-4.068407,"marketCap":45260576},{"date":"2025-02-21","current":-2.447061,"twenty":-20.872975,"median":-5.908467,"eighty":-3.946872,"marketCap":43506290},{"date":"2025-02-28","current":-2.348389,"twenty":-20.794135,"median":-5.885273,"eighty":-3.784683,"marketCap":41752004},{"date":"2025-03-07","current":-2.210248,"twenty":-20.498484,"median":-5.867165,"eighty":-3.670591,"marketCap":39296004},{"date":"2025-03-14","current":-2.109947,"twenty":-20.183123,"median":-5.776622,"eighty":-3.453513,"marketCap":37512750},{"date":"2025-03-21","current":-2.151728,"twenty":-20.183123,"median":-5.722296,"eighty":-3.368187,"marketCap":38255577},{"date":"2025-03-28","current":-2.130838,"twenty":-20.005732,"median":-5.595537,"eighty":-3.295638,"marketCap":37884163},{"date":"2025-04-04","current":-2.958372,"twenty":-19.926892,"median":-5.518575,"eighty":-3.165965,"marketCap":33018387},{"date":"2025-04-11","current":-2.748074,"twenty":-19.788921,"median":-5.342017,"eighty":-3.105834,"marketCap":30671251},{"date":"2025-04-17","current":-3.685286,"twenty":-19.647008,"median":-5.282987,"eighty":-3.104326,"marketCap":41131477},{"date":"2025-04-25","current":-4.361485,"twenty":-19.501154,"median":-5.215258,"eighty":-3.131377,"marketCap":48678537},{"date":"2025-05-02","current":-3.496805,"twenty":-18.968982,"median":-5.142823,"eighty":-3.15355,"marketCap":39027837},{"date":"2025-05-09","current":-2.900977,"twenty":-18.732461,"median":-5.107537,"eighty":-3.105179,"marketCap":32377800},{"date":"2025-05-16","current":-5.090366,"twenty":-18.693381,"median":-5.090366,"eighty":-3.095239,"marketCap":39027837},{"date":"2025-05-23","current":-4.291877,"twenty":-18.607387,"median":-5.049055,"eighty":-3.101704,"marketCap":32905823},{"date":"2025-05-30","current":-3.742916,"twenty":-18.421041,"median":-5.00701,"eighty":-3.104523,"marketCap":28696939},{"date":"2025-06-06","current":-4.262932,"twenty":-18.227882,"median":-4.979847,"eighty":-3.124991,"marketCap":32683900},{"date":"2025-06-13","current":-4.354259,"twenty":-18.018955,"median":-4.934576,"eighty":-3.149603,"marketCap":33384106},{"date":"2025-06-20","current":-3.674878,"twenty":-17.856887,"median":-4.868731,"eighty":-3.157497,"marketCap":28175292},{"date":"2025-06-27","current":-3.644169,"twenty":-17.748258,"median":-4.815121,"eighty":-3.160884,"marketCap":27939844},{"date":"2025-07-03","current":-3.132347,"twenty":-17.688614,"median":-4.795627,"eighty":-3.157497,"marketCap":24015708},{"date":"2025-07-11","current":-3.321721,"twenty":-17.510817,"median":-4.711647,"eighty":-3.13343,"marketCap":25467638},{"date":"2025-07-18","current":-3.531568,"twenty":-17.278608,"median":-4.698155,"eighty":-3.14171,"marketCap":27076534},{"date":"2025-07-25","current":-3.36062,"twenty":-17.22661,"median":-4.675331,"eighty":-3.157497,"marketCap":25765873},{"date":"2025-08-01","current":-3.260303,"twenty":-17.184807,"median":-4.665775,"eighty":-3.157497,"marketCap":24996742},{"date":"2025-08-08","current":-1.692292,"twenty":-16.92818,"median":-4.639671,"eighty":-3.111465,"marketCap":22377179},{"date":"2025-08-15","current":-1.862725,"twenty":-16.567638,"median":-4.558872,"eighty":-3.098103,"marketCap":24630815},{"date":"2025-08-22","current":-1.865576,"twenty":-16.533025,"median":-4.524553,"eighty":-3.074912,"marketCap":24668515},{"date":"2025-08-29","current":-1.964732,"twenty":-16.426305,"median":-4.50321,"eighty":-3.015849,"marketCap":25979645},{"date":"2025-09-05","current":-1.881416,"twenty":-16.368618,"median":-4.425233,"eighty":-2.962429,"marketCap":24877961},{"date":"2025-09-12","current":-1.789547,"twenty":-16.310932,"median":-4.376497,"eighty":-2.933582,"marketCap":23663176},{"date":"2025-09-19","current":-1.694826,"twenty":-16.29651,"median":-4.361485,"eighty":-2.897365,"marketCap":22410690},{"date":"2025-09-26","current":-1.709716,"twenty":-15.863859,"median":-4.348021,"eighty":-2.853034,"marketCap":22607569},{"date":"2025-10-03","current":-1.710666,"twenty":-15.863859,"median":-4.327761,"eighty":-2.748074,"marketCap":22620136},{"date":"2025-10-10","current":-1.544034,"twenty":-15.807485,"median":-4.261494,"eighty":-2.486529,"marketCap":20416767},{"date":"2025-10-17","current":-1.298839,"twenty":-15.630094,"median":-4.210794,"eighty":-2.348389,"marketCap":17174548},{"date":"2025-10-24","current":-1.301056,"twenty":-15.503317,"median":-4.186877,"eighty":-2.318853,"marketCap":17203870},{"date":"2025-10-31","current":-1.257339,"twenty":-14.972667,"median":-4.132817,"eighty":-2.297962,"marketCap":16625800},{"date":"2025-11-07","current":-0.932278,"twenty":-13.927049,"median":-4.072247,"eighty":-2.249717,"marketCap":17248077},{"date":"2025-11-14","current":-0.933669,"twenty":-13.245174,"median":-4.04235,"eighty":-2.172619,"marketCap":17273805},{"date":"2025-11-21","current":-0.902797,"twenty":-13.070223,"median":-4.004863,"eighty":-2.130838,"marketCap":16702642},{"date":"2025-11-28","current":-0.907742,"twenty":-12.733301,"median":-3.95212,"eighty":-2.105769,"marketCap":16794130},{"date":"2025-12-05","current":-0.861361,"twenty":-11.417566,"median":-3.918378,"eighty":-2.038689,"marketCap":15936036},{"date":"2025-12-12","current":-1.151904,"twenty":-11.10969,"median":-3.880347,"eighty":-1.962831,"marketCap":21311383},{"date":"2025-12-19","current":-0.864342,"twenty":-10.563644,"median":-3.855551,"eighty":-1.925449,"marketCap":15991199},{"date":"2025-12-26","current":-0.781519,"twenty":-10.366139,"median":-3.817676,"eighty":-1.905048,"marketCap":14458888},{"date":"2026-01-02","current":-0.80862,"twenty":-10.104734,"median":-3.784683,"eighty":-1.867667,"marketCap":14960285},{"date":"2026-01-09","current":-1.186504,"twenty":-9.756195,"median":-3.726488,"eighty":-1.863485,"marketCap":21951508},{"date":"2026-01-16","current":-1.21347,"twenty":-9.439605,"median":-3.689721,"eighty":-1.817994,"marketCap":22450406},{"date":"2026-01-23","current":-1.222459,"twenty":-8.832939,"median":-3.685286,"eighty":-1.804182,"marketCap":22616705},{"date":"2026-01-30","current":-1.226773,"twenty":-8.114091,"median":-3.670176,"eighty":-1.745069,"marketCap":22696529},{"date":"2026-02-06","current":-0.81653,"twenty":-7.942868,"median":-3.64061,"eighty":-1.71998,"marketCap":15106628},{"date":"2026-02-13","current":-0.884485,"twenty":-7.806733,"median":-3.5628,"eighty":-1.705851,"marketCap":16363851},{"date":"2026-02-20","current":-0.903181,"twenty":-7.769521,"median":-3.544415,"eighty":-1.692292,"marketCap":16709754},{"date":"2026-02-27","current":-1.025558,"twenty":-7.720912,"median":-3.492982,"eighty":-1.665999,"marketCap":19122546},{"date":"2026-03-06","current":-1.519667,"twenty":-7.689204,"median":-3.463009,"eighty":-1.553538,"marketCap":28335707},{"date":"2026-03-13","current":-1.232917,"twenty":-7.578225,"median":-3.43637,"eighty":-1.519667,"marketCap":22988964},{"date":"2026-03-20","current":-0.927678,"twenty":-7.514809,"median":-3.414459,"eighty":-1.43094,"marketCap":17297489},{"date":"2026-03-27","current":-0.797535,"twenty":-7.246713,"median":-3.39431,"eighty":-1.385333,"marketCap":14870838},{"date":"2026-04-02","current":-0.241073,"twenty":-7.177005,"median":-3.378022,"eighty":-1.359957,"marketCap":4495048},{"date":"2026-04-10","current":-0.336129,"twenty":-7.067291,"median":-3.359084,"eighty":-1.328997,"marketCap":6267453},{"date":"2026-04-17","current":-0.370229,"twenty":-6.822821,"median":-3.321721,"eighty":-1.299599,"marketCap":6903282},{"date":"2026-04-24","current":-0.367793,"twenty":-6.742593,"median":-3.30892,"eighty":-1.267223,"marketCap":6857865},{"date":"2026-05-01","current":-0.368753,"twenty":-6.533559,"median":-3.275657,"eighty":-1.232416,"marketCap":6875767},{"date":"2026-05-08","current":-0.345774,"twenty":-6.468368,"median":-3.258236,"eighty":-1.221308,"marketCap":6459054},{"date":"2026-05-15","current":-0.312154,"twenty":-6.322318,"median":-3.235952,"eighty":-1.201893,"marketCap":5831040},{"date":"2026-05-22","current":-0.303483,"twenty":-6.255297,"median":-3.19076,"eighty":-1.171044,"marketCap":5669067},{"date":"2026-05-29","current":-0.326606,"twenty":-6.214848,"median":-3.171598,"eighty":-1.119059,"marketCap":6100996},{"date":"2026-06-05","current":-0.309264,"twenty":-6.16305,"median":-3.157497,"eighty":-1.023143,"marketCap":5777049},{"date":"2026-06-12","current":-0.278626,"twenty":-6.143005,"median":-3.135055,"eighty":-0.995266,"marketCap":5204743},{"date":"2026-06-18","current":-0.231225,"twenty":-6.14132,"median":-3.119296,"eighty":-0.966672,"marketCap":4319289},{"date":"2026-06-26","current":-0.211918,"twenty":-6.088089,"median":-3.102557,"eighty":-0.949468,"marketCap":3958628},{"date":"2026-07-02","current":-0.261949,"twenty":-6.010483,"median":-3.098055,"eighty":-0.939027,"marketCap":4893215},{"date":"2026-07-10","current":-0.248856,"twenty":-6.001989,"median":-3.08079,"eighty":-0.932373,"marketCap":4648635},{"date":"2026-07-17","current":-0.242729,"twenty":-5.989422,"median":-3.058826,"eighty":-0.919078,"marketCap":4534174},{"date":"2026-07-24","current":-0.212583,"twenty":-5.964951,"median":-3.025992,"eighty":-0.912766,"marketCap":3971046}],"updateTime":1785077777111},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FBLG\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1157352361","title":"FibroBiologics提交SEC文件：註冊出售股東至多1253萬股普通股轉售","url":"https://stock-news.laohu8.com/highlight/detail?id=1157352361","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157352361?lang=zh_tw&edition=fundamental","pubTime":"2026-07-10 18:07","pubTimestamp":1783678031,"startTime":"0","endTime":"0","summary":"FibroBiologics已向美国证券交易委员会提交文件，为其部分出售股东注册了高达1253万股普通股的转售资格。此举意味着，持有这些已注册股份的股东未来可在公开市场出售这些股票，而公司本身不会从此次转售中获得任何收益。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128222368","title":"FibroBiologics完成第三批Cywc628藥物生產，用於糖尿病足潰瘍1/2期臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1128222368","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128222368?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 20:35","pubTimestamp":1783427707,"startTime":"0","endTime":"0","summary":"FibroBiologics宣布，已完成用于糖尿病足溃疡1/2期临床试验的第三批Cywc628药物产品的生产工作。该进展标志着公司针对这一适应症的临床开发计划取得了关键一步，为后续的试验推进提供了必要的材料保障。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150619750","title":"FibroBiologics宣佈完成最高900萬美元按市價定價的私募配售","url":"https://stock-news.laohu8.com/highlight/detail?id=1150619750","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150619750?lang=zh_tw&edition=fundamental","pubTime":"2026-06-30 04:02","pubTimestamp":1782763335,"startTime":"0","endTime":"0","summary":"FibroBiologics公司宣布，其依据纳斯达克规则按市价定价的私募配售已正式完成，此次融资规模最高可达900万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167139626","title":"FibroBiologics獲美國專利授權通知，覆蓋用於傷口癒合的局部成纖維細胞球體療法","url":"https://stock-news.laohu8.com/highlight/detail?id=1167139626","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167139626?lang=zh_tw&edition=fundamental","pubTime":"2026-06-22 20:32","pubTimestamp":1782131575,"startTime":"0","endTime":"0","summary":"FibroBiologics公司已收到关于一项美国专利的授权通知，该专利涵盖了用于伤口愈合的局部成纤维细胞球体疗法。这一进展标志着该公司在再生医学领域的技术开发取得了重要里程碑。成纤维细胞球体疗法是一种创新的治疗方式，旨在通过局部应用促进组织修复和伤口愈合。专利的授权将为该疗法的进一步开发和商业化提供关键的知识产权保护。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115715028","title":"FibroBiologics推進針對糖尿病足潰瘍的Ciwc628藥物1/2期臨床試驗患者給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=1115715028","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115715028?lang=zh_tw&edition=fundamental","pubTime":"2026-06-16 20:31","pubTimestamp":1781613092,"startTime":"0","endTime":"0","summary":"FibroBiologics公司宣布，其用于治疗糖尿病足溃疡的研究性药物Ciwc628的1/2期临床试验已取得进展，进入患者给药阶段。这一步骤标志着该疗法在临床开发路径上的重要推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156476620","title":"FibroBiologics宣佈首批患者接受Cywc628治療糖尿病足潰瘍的1/2期臨床試驗給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=1156476620","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156476620?lang=zh_tw&edition=fundamental","pubTime":"2026-06-03 19:02","pubTimestamp":1780484567,"startTime":"0","endTime":"0","summary":"FibroBiologics宣布，其用于治疗糖尿病足溃疡的在研药物Cywc628，已在1/2期临床试验中为首批患者完成给药。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119164458","title":"新聞稿：FibroBiologics 在皮膚研究學會2026年會上公布臨床前數據，展示其銀屑病療法持久的免疫調節作用","url":"https://stock-news.laohu8.com/highlight/detail?id=1119164458","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119164458?lang=zh_tw&edition=fundamental","pubTime":"2026-05-22 20:31","pubTimestamp":1779453094,"startTime":"0","endTime":"0","summary":"FibroBiologics  是一家拥有超过270项已授权和申请中专利的临床阶段生物技术公司，专注于利用成纤维细胞及其衍生材料开发慢性疾病的治疗方法和潜在治愈方案。该公司今日公布了其针对银屑病的CYPS317项目在皮肤研究学会2026年会上展示的临床前数据。该年会于2026年5月13日至15日在伊利诺伊州芝加哥举行。这些前瞻性声明基于FibroBiologics管理层当前的预期、估计、预测和信念，以及对未来事件的一系列假设。FibroBiologics不保证其能够实现预期。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131452413","title":"FibroBiologics啓動1/2期臨床試驗 評估CYWc628對糖尿病足潰瘍患者的安全性、耐受性及療效","url":"https://stock-news.laohu8.com/highlight/detail?id=1131452413","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131452413?lang=zh_tw&edition=fundamental","pubTime":"2026-05-04 20:31","pubTimestamp":1777897876,"startTime":"0","endTime":"0","summary":"生物技术公司FibroBiologics宣布，将开展一项针对糖尿病足溃疡患者的1/2期临床研究。该试验旨在系统评估候选药物CYWc628在患者群体中的安全性表现、耐受性水平以及潜在治疗效果。\n这项临床研究的推进，标志着FibroBiologics在细胞疗法领域取得了新的阶段性进展。通过严谨的临床试验设计，公司期望为糖尿病足溃疡这一难治性疾病的治疗提供新的解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170332450","title":"FibroBiologics宣佈Cywc628藥物產品完成生產 將用於糖尿病足潰瘍1/2期臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1170332450","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170332450?lang=zh_tw&edition=fundamental","pubTime":"2026-05-04 20:30","pubTimestamp":1777897838,"startTime":"0","endTime":"0","summary":"生物技术公司FibroBiologics正式宣布，其针对糖尿病足溃疡治疗的核心候选药物Cywc628已完成生产放行流程。该批药物将立即投入即将启动的1/2期临床试验阶段，标志着公司在纤维细胞疗法领域取得关键进展。\n此次药物放行严格遵循药品生产质量管理规范，确保临床试验用药的安全性与稳定性。糖尿病足溃疡作为糖尿病最常见的严重并发症之一，目前临床治疗手段有限，Cywc628的推进将为患者提供潜在的新型治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156447376","title":"FibroBiologics達成ATM發行協議 擬發售最高615萬美元普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1156447376","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156447376?lang=zh_tw&edition=fundamental","pubTime":"2026-05-02 04:04","pubTimestamp":1777665867,"startTime":"0","endTime":"0","summary":"再生医学公司FibroBiologics（股票代码：FBLG）近日向美国证券交易委员会（SEC）提交文件，宣布已签订一项市场发行（ATM）协议。根据该协议，公司获权通过承销商发售价值最高达615万美元的普通股。\nATM发行机制允许上市公司根据市场情况灵活择机发售新股，此举将为FibroBiologics提供额外的运营资金。该公司专注于利用成纤维细胞技术开发慢性疾病创新疗法，此次融资将加速其细胞疗法管线的临床推进。\n此次发行具体条款将取决于市场条件、股价波动及公司资金需求等因素。通过这种股权融资方式，FibroBiologics有望在保持资金灵活性的同时，为长期研发投入提供支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125810558","title":"FibroBiologics與United Fire & Casualty簽訂租約終止協議，生效日期為2026年4月3日","url":"https://stock-news.laohu8.com/highlight/detail?id=1125810558","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125810558?lang=zh_tw&edition=fundamental","pubTime":"2026-04-10 04:22","pubTimestamp":1775766154,"startTime":"0","endTime":"0","summary":"根据向美国证券交易委员会（SEC）提交的文件，FibroBiologics公司已与United Fire & Casualty达成一项租约终止协议，该协议将于2026年4月3日正式生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128604799","title":"FibroBiologics宣佈成功生產Cywc628藥物產品，為即將開展的糖尿病足潰瘍臨床試驗提供支持","url":"https://stock-news.laohu8.com/highlight/detail?id=1128604799","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128604799?lang=zh_tw&edition=fundamental","pubTime":"2026-04-01 04:16","pubTimestamp":1774988194,"startTime":"0","endTime":"0","summary":"FibroBiologics公司近日宣布，已成功完成Cywc628药物产品的生产工作，该产品将用于支持即将启动的糖尿病足溃疡临床试验。这一进展标志着公司在细胞纤维化治疗领域迈出重要一步，也为后续临床研究奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150891053","title":"FibroBiologics宣佈實施合股計劃，旨在重新符合納斯達克最低買入價規定","url":"https://stock-news.laohu8.com/highlight/detail?id=1150891053","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150891053?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 04:31","pubTimestamp":1774470675,"startTime":"0","endTime":"0","summary":"FibroBiologics（股票代码：FBLG）近日公布一项重要举措，公司将进行反向股票分割（reverse stock split），以恢复对纳斯达克交易所最低买入价要求的合规状态。此举旨在通过调整流通股数量，提升每股市场交易价格，从而满足交易所持续上市标准中关于股价的规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618873861","title":"Fibrobiologics, Inc.盤中異動 早盤急速下跌5.30%報0.375美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618873861","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618873861?lang=zh_tw&edition=fundamental","pubTime":"2026-03-11 22:29","pubTimestamp":1773239341,"startTime":"0","endTime":"0","summary":"北京时间2026年03月11日22时29分，Fibrobiologics, Inc.股票出现波动，股价大幅下挫5.30%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031122290197addcdc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031122290197addcdc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617578712","title":"Fibrobiologics, Inc.盤中異動 大幅上漲5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617578712","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617578712?lang=zh_tw&edition=fundamental","pubTime":"2026-03-05 22:33","pubTimestamp":1772721185,"startTime":"0","endTime":"0","summary":"北京时间2026年03月05日22时33分，Fibrobiologics, Inc.股票出现波动，股价急速上涨5.94%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030522330695432e4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030522330695432e4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4007","BK4139","IBO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180594991","title":"FibroBiologics完成針對難治性糖尿病足潰瘍的Cywc628一期/二期臨床試驗中心啓動工作","url":"https://stock-news.laohu8.com/highlight/detail?id=1180594991","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180594991?lang=zh_tw&edition=fundamental","pubTime":"2026-03-05 21:31","pubTimestamp":1772717517,"startTime":"0","endTime":"0","summary":"生物技术公司FibroBiologics已顺利完成针对候选药物Cywc628的一期/二期临床试验中心启动流程。该试验旨在评估Cywc628在治疗难治性糖尿病足溃疡方面的安全性与有效性。这一关键进展为后续患者入组及临床研究开展奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159497620","title":"FibroBiologics公司宣佈獲得美國專利，涵蓋用於治療骨質疏鬆的成纖維細胞療法","url":"https://stock-news.laohu8.com/highlight/detail?id=1159497620","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159497620?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 21:33","pubTimestamp":1772458424,"startTime":"0","endTime":"0","summary":"FibroBiologics公司近日宣布，其针对骨质疏松症治疗的成纤维细胞疗法已获得美国专利授权。这一专利的授予标志着该公司在细胞治疗领域，特别是在骨骼疾病治疗方向取得了重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612463025","title":"Fibrobiologics, Inc.盤中異動 早盤快速拉升5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612463025","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612463025?lang=zh_tw&edition=fundamental","pubTime":"2026-02-17 22:30","pubTimestamp":1771338639,"startTime":"0","endTime":"0","summary":"北京时间2026年02月17日22时30分，Fibrobiologics, Inc.股票出现波动，股价快速上涨5.34%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021722303997a6669e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021722303997a6669e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FBLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611979289","title":"Fibrobiologics, Inc.盤中異動 早盤股價大跌5.58%報0.241美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611979289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611979289?lang=zh_tw&edition=fundamental","pubTime":"2026-02-13 00:11","pubTimestamp":1770912688,"startTime":"0","endTime":"0","summary":"北京时间2026年02月13日00时11分，Fibrobiologics, Inc.股票出现异动，股价大幅下挫5.58%。Fibrobiologics, Inc.股票所在的生物技术行业中，整体涨幅为0.61%。Fibrobiologics, Inc.公司简介：FibroBiologics Inc 是一家临床阶段细胞治疗公司，专注开发和商业化基于成纤维细胞的治疗方法，用于治疗患有严重未满足医疗需求的慢性疾病的患者，包括退行性椎间盘疾病、多发性硬化症、伤口愈合和某些癌症以及潜在的延长生命应用，包括胸腺和脾脏退化逆转。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602130011289540f00a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602130011289540f00a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FBLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104774145","title":"FibroBiologics獲加拿大專利授權，覆蓋基於成纖維細胞的惡病質創新療法","url":"https://stock-news.laohu8.com/highlight/detail?id=1104774145","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104774145?lang=zh_tw&edition=fundamental","pubTime":"2026-02-05 21:31","pubTimestamp":1770298293,"startTime":"0","endTime":"0","summary":"FibroBiologics宣布，其针对恶病质开发的新型成纤维细胞疗法已获得加拿大专利授权。该专利进一步巩固了公司在细胞治疗领域的技术布局与知识产权保护。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBLG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}]}}